Literature DB >> 19521966

Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development.

Ronald G Iacocca1, Christopher L Burcham, Lori R Hilden.   

Abstract

A strategy for physical property control of a drug substance has been developed that utilizes a science-based approach to define key drivers for particle control. These drivers are based on in vivo performance (or expected performance), content uniformity of the drug substance in drug product, and manufacturability of drug product. Quality by design principles have been used in developing the strategy. The strategy has been designed to provide expectations in terms of particle control at each state of development, translating to early-phase projects and carrying through until launch and beyond.

Mesh:

Substances:

Year:  2010        PMID: 19521966     DOI: 10.1002/jps.21801

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.

Authors:  Eleftherios Kougoulos; Ian Smales; Hugh M Verrier
Journal:  AAPS PharmSciTech       Date:  2011-01-19       Impact factor: 3.246

2.  Development of a material sparing bulk density test comparable to a standard USP method for use in early development of API's.

Authors:  Helen Hughes; Michael M Leane; Michael Tobyn; John F Gamble; Santiago Munoz; Pauline Musembi
Journal:  AAPS PharmSciTech       Date:  2014-09-19       Impact factor: 3.246

3.  Effect of raw material variability of glipizide on the in vitro dissolution rate and in vivo bioavailability performance: The importance of particle size.

Authors:  Chenyao Zhao; Chan Jin; Hailing Gao; Liyuan Wang; Hongzhuo Liu; Zhonggui He
Journal:  Asian J Pharm Sci       Date:  2018-08-28       Impact factor: 6.598

4.  Raman Mapping-Based Reverse Engineering Facilitates Development of Sustained-Release Nifedipine Tablet.

Authors:  Ningyun Sun; Liang Chang; Yi Lu; Wei Wu
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

5.  Assessment of active pharmaceutical ingredient particle size in tablets by Raman chemical imaging validated using polystyrene microsphere size standards.

Authors:  Atsushi Kuriyama; Yukihiro Ozaki
Journal:  AAPS PharmSciTech       Date:  2014-01-11       Impact factor: 3.246

6.  Measuring Bismuth Oxide Particle Size and Morphology in Film-Coated Tablets.

Authors:  Stefani Fertaki; Georgios Bagourakis; Malvina Orkoula; Christos Kontoyannis
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.